Zenas BioPharma Ratios (2023-2025) | ZBIO

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 71.25%-1,130.68%-337.78%
EBIT Margin 71.25%-1,112.46%-373.30%
EBITDA Margin 71.23%-1,049.26%-336.26%
Operating Margin 71.25%-1,112.46%-373.30%
Net Margin 71.25%-1,130.68%-335.73%
FCF Margin -772.56%-370.69%
Efficiency
Assets Average 386.70M351.87M313.43M307.55M
Equity Average -213.98M-239.11M-270.64M35.33M335.95M298.39M261.97M218.03M
Invested Capital -202.23M-225.72M-252.50M-288.78M359.44M312.46M284.32M239.63M196.43M
Leverage & Solvency
Debt to Equity 0.37
Debt Ratio 0.23
Equity Ratio -3.310.890.840.850.820.61
Valuation
Enterprise Value -72.31M-56.86M-37.24M-184.02M501.19M-8.50M-22.56M-98.80M457.93M
Market Capitalization 861.31M342.27M407.46M405.37M934.85M
Return Ratios
Return on Capital Employed -0.50%-0.57%-0.73%-0.79%
Return on Assets -0.42%-0.47%-0.58%-0.63%
Return on Equity 0.20%-3.66%-0.48%-0.56%-0.69%-0.89%